Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
Ann Oncol. 2015 Dec;26(12):2505-6.
doi: 10.1093/annonc/mdv478.
Epub 2015 Oct 13.